Literature DB >> 17918822

Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.

Leggy A Arnold1, Aaron Kosinski, Eva Estébanez-Perpiñá, Robert J Fletterick, R Kiplin Guy.   

Abstract

The modulation of gene regulation by blocking the interaction between the thyroid receptor (TR) and obligate coregulators has been reported recently with the discovery of the lead compound 3-(dimethylamino)-1-(4-hexylphenyl)propan-1-one). Herein we report studies aimed at optimization of this initial hit to determine the basic parameters of the structure-activity relationships and clarify the mechanism of action. These studies provided new insights, showing that activity and TRbeta isoform selectivity is highly correlated with the structural composition of these covalent inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17918822      PMCID: PMC2536611          DOI: 10.1021/jm070556y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  29 in total

Review 1.  Transcriptional repression by nuclear hormone receptors.

Authors:  X Hu; M A Lazar
Journal:  Trends Endocrinol Metab       Date:  2000 Jan-Feb       Impact factor: 12.015

2.  An inhibitor of the interaction of thyroid hormone receptor beta and glucocorticoid interacting protein 1.

Authors:  T R Geistlinger; R K Guy
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

Review 3.  Nuclear hormone receptors and gene expression.

Authors:  A Aranda; A Pascual
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

4.  Quantitative proteomics of the thyroid hormone receptor-coregulator interactions.

Authors:  Jamie M R Moore; Sarah J Galicia; Andrea C McReynolds; Ngoc-Ha Nguyen; Thomas S Scanlan; R Kiplin Guy
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

5.  Overexpression of thyroid hormone receptor beta1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line.

Authors:  S T Chen; H Y Shieh; J D Lin; K S Chang; K H Lin
Journal:  J Endocrinol       Date:  2000-05       Impact factor: 4.286

Review 6.  Mechanism of thyroid hormone action.

Authors:  Clare B Harvey; Graham R Williams
Journal:  Thyroid       Date:  2002-06       Impact factor: 6.568

7.  PAMPA--a drug absorption in vitro model. 5. Unstirred water layer in iso-pH mapping assays and pKa(flux)--optimized design (pOD-PAMPA).

Authors:  Jeffrey A Ruell; Konstantin L Tsinman; Alex Avdeef
Journal:  Eur J Pharm Sci       Date:  2003-12       Impact factor: 4.384

8.  Novel selective inhibitors of the interaction of individual nuclear hormone receptors with a mutually shared steroid receptor coactivator 2.

Authors:  Timothy R Geistlinger; R Kiplin Guy
Journal:  J Am Chem Soc       Date:  2003-06-11       Impact factor: 15.419

9.  Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.

Authors:  Elisabeth Davioud-Charvet; Michael J McLeish; Donna M Veine; David Giegel; L David Arscott; Adriano D Andricopulo; Katja Becker; Sylke Müller; R Heiner Schirmer; Charles H Williams; George L Kenyon
Journal:  Biochemistry       Date:  2003-11-18       Impact factor: 3.162

Review 10.  Review of the in vivo functions of the p160 steroid receptor coactivator family.

Authors:  Jianming Xu; Qingtian Li
Journal:  Mol Endocrinol       Date:  2003-06-12
View more
  15 in total

1.  Similarities and differences between two modes of antagonism of the thyroid hormone receptor.

Authors:  Prabodh Sadana; Jong Yeon Hwang; Ramy R Attia; Leggy A Arnold; Geoffrey Neale; R Kiplin Guy
Journal:  ACS Chem Biol       Date:  2011-08-15       Impact factor: 5.100

Review 2.  Transcriptional switches: chemical approaches to gene regulation.

Authors:  Lori W Lee; Anna K Mapp
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

Review 3.  Steroid receptor/coactivator binding inhibitors: An update.

Authors:  Kornelia J Skowron; Kenneth Booker; Changfeng Cheng; Simone Creed; Brian P David; Phillip R Lazzara; Amy Lian; Zamia Siddiqui; Thomas E Speltz; Terry W Moore
Journal:  Mol Cell Endocrinol       Date:  2019-06-01       Impact factor: 4.102

4.  A quantitative high-throughput screen identifies novel inhibitors of the interaction of thyroid receptor beta with a peptide of steroid receptor coactivator 2.

Authors:  Ronald L Johnson; Jong Yeon Hwang; Leggy A Arnold; Ruili Huang; Jennifer Wichterman; Indre Augustinaite; Christopher P Austin; James Inglese; R Kiplin Guy; Wenwei Huang
Journal:  J Biomol Screen       Date:  2011-04-11

5.  Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.

Authors:  Aiming Sun; Terry W Moore; Jillian R Gunther; Mi-Sun Kim; Eric Rhoden; Yuhong Du; Haian Fu; James P Snyder; John A Katzenellenbogen
Journal:  ChemMedChem       Date:  2011-03-01       Impact factor: 3.466

6.  Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone.

Authors:  Jong Yeon Hwang; Wenwei Huang; Leggy A Arnold; Ruili Huang; Ramy R Attia; Michele Connelly; Jennifer Wichterman; Fangyi Zhu; Indre Augustinaite; Christopher P Austin; James Inglese; Ronald L Johnson; R Kiplin Guy
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

Review 7.  Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).

Authors:  Terry W Moore; Christopher G Mayne; John A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2009-11-20

8.  Prediction of binding affinity and efficacy of thyroid hormone receptor ligands using QSAR and structure-based modeling methods.

Authors:  Regina Politi; Ivan Rusyn; Alexander Tropsha
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-21       Impact factor: 4.219

9.  Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.

Authors:  Premchendar Nandhikonda; Wen Z Lynt; Megan M McCallum; Tahniyath Ara; Athena M Baranowski; Nina Y Yuan; Dana Pearson; Daniel D Bikle; R Kiplin Guy; Leggy A Arnold
Journal:  J Med Chem       Date:  2012-05-16       Impact factor: 7.446

10.  Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.

Authors:  Jong Yeon Hwang; Leggy A Arnold; Fangyi Zhu; Aaron Kosinski; Thomas J Mangano; Vincent Setola; Bryan L Roth; R Kiplin Guy
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.